Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,016 | Dovepress* | 6,070+ | 1,379 | 7,449 | |
PubMed Central* | 946 | 392 | 1,338 | ||
Totals | 7,016 | 1,771 | 8,787 | ||
*Since 16 March 2016 +Since July 2016 |
View citations on PubMed Central and Google Scholar